The serotonin transporter: a vehicle to elucidate pulmonary hypertension?

نویسندگان

  • E Kenneth Weir
  • Zhigang Hong
  • Anthony Varghese
چکیده

Primary pulmonary hypertension (PPH) is a lifethreatening disease that mostly affects young adults, more commonly women than men. It is characterized by vasoconstriction of the small pulmonary arteries, proliferation in all layers of the vessel wall, thrombosis-in situ, and inflammation. Serotonin (5-hydroxytryptamine, 5-HT) is thought to play a role in the pathogenesis of PPH, in part, because it is a pulmonary vasoconstrictor1 and smooth muscle mitogen.2,3 It is synthesized from L-tryptophan, primarily in the enterochromaffin cells of the small intestine. In the blood, 5-HT is mainly transported in the platelets, some are bound to plasma proteins, and only nanomolar concentrations are free in the plasma. The importance of the lungs in the removal of 5-HT from the blood has been known for more than 50 years.4 As much as 95% may be taken up or inactivated.5 5-HT is taken up by the 5-HT transporter (5-HTT) in several cells including platelets, neurons, and pulmonary artery smooth muscle and endothelial cells. 5-HTT belongs to a large 12 transmembrane–domain gene family including the norepinephine transporter, glucose transporters, and transporters of other neurotransmitters. The amino acid sequence of cloned human 5-HTT reveals 6 putative phosphorylation sites, targets for PKA and PKC, which may activate 5-HTT. The Figure shows some of the cellular signaling pathways involving 5-HTT and 5-HT receptors. Herve et al have described elevated plasma levels of 5-HT in PPH patients, even after bilateral lung transplantation.6 This implies that 5-HT is an etiologic agent or is linked to an etiologic agent, either genetically or by being released through exocytosis, along with an etiologic agent. Other evidence implicating 5-HT is the report of PPH in a patient with platelet storage pool disease who had elevated plasma 5-HT levels.7 Similarly, the fawn-hooded rat has a genetic defect in platelet storage of 5-HT and develops pulmonary hypertension in mild hypoxia.8 Finally, the anorectic agents fenfluramine and dexfenfluramine, which block the 5-HTT, have been associated with outbreaks of PPH.9 Contrary to prior supposition, dexfenfluramine, at concentrations attained clinically, does not cause the release of 5-HT from platelets,10 but does inhibit platelet uptake of 5-HT and, at least in rats exposed to mild hypoxia, increases the plasma levels of 5-HT.11 These reports suggest that 5-HT is an etiologic agent in the pathophysiology of PPH. However, it is clear that the majority of patients with carcinoid syndrome, in which high levels of 5-HT are released from this tumor of the enterochromaffin cells, do not develop PPH, nor do most of the patients on dexfenfluramine. Consequently, there have to be other factors that determine susceptibility. One such susceptibility factor is a mutation in the gene for the bone morphogenetic protein receptor (BMPR II). BMPR II is an inhibitory receptor in the transforming growth factor (TGF) superfamily that is present in most patients with the familial form of PPH and in less than a quarter of those with the sporadic form of PPH.12–14 Even in the absence of a BMPR II mutation, BMPR II expression can be reduced in some PPH patients.15 Loss of inhibitory signaling from this pathway may make the smooth muscle and endothelial cells more susceptible to proliferation induced by 5-HT and other mediators. Another abnormality that may determine susceptibility is a decrease in potassium (K ) channel expression in the smooth muscle cells (SMCs) of patients with PPH, specifically Kv1.5.16 Kv channel genes are known to be downregulated in the lungs of PPH patients.17 A decrease in the outward K current causes membrane depolarization and calcium entry through L-type calcium channels that promote both vasoconstriction and proliferation. Anorectic agents, such as dexfenfluramine, also inhibit K current,18; thus, a decrease in K channel function or expression may increase susceptibility to PPH. In addition, dexfenfluramine and K channel blockers can stimulate 5-HT release from the ileum,19 which raises the possibility that there might be a connection between K channel function or expression and increased plasma 5-HT levels. Susceptibility to PPH is also increased in patients who are homozygous for the L-allele variant of the 5-HTT gene promoter, which is associated with 5-HTT overexpression.20 The role of 5-HTT is emphasized by the finding that mice deficient for 5-HTT develop less chronic hypoxic pulmonary hypertension (PH) than wild-type mice,21 whereas mice that overexpress 5-HTT develop more severe PH.22 In the current issue of Circulation Research, Marcos et al build on their prior body of work implicating 5-HTT in the pathophysiology of PH.23 Using human lung tissue, they show that immunostaining for 5-HTT is greater in the pulmonary arteries of PPH patients than in secondary PH patients, which is, in turn, greater than in patients without PH. No difference was seen in 5-HT receptors (5-HT1B, 2A, or 2B). Likewise, in cultured pulmonary artery SMCs, the mRNA for 5-HTT, the growth in response to 5-HT, and the 5-HT uptake are greater in PPH The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association. From the Department of Medicine, VA Medical Center and the University of Minnesota, Minneapolis, Minn. Correspondence to E. Kenneth Weir, MD, VA Medical Center (111C), One Veteran Drive, Minneapolis, MN 55417. E-mail weirx002@ umn.edu (Circ Res. 2004;94:1152–1154.) © 2004 American Heart Association, Inc.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.

Pulmonary hypertension (PH) results from constriction and remodeling of pulmonary vessels. Serotonin contributes to both phenomena through different signaling pathways. The mitogenic effect of serotonin on pulmonary vascular smooth muscle cells is mediated by the serotonin transporter (5-hydroxytryptamine transporter [5-HTT]), whereas its constricting effect is mediated by 5-HT1B/1D and 5-HT2A ...

متن کامل

The pulmonary hypertensive fawn-hooded rat has a normal serotonin transporter coding sequence.

The coding sequence of the serotonin transporter gene was compared in two strains of rat-the Wistar and the fawn-hooded rat (FHR). The FHR has an inherited platelet storage-pool deficiency and a widespread impairment of serotonin storage. It is also susceptible to systemic and pulmonary hypertension. The FHR provides a model to study the genetics in human systemic and pulmonary hypertension. We...

متن کامل

The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series)

Increased synthesis of serotonin and/or activity of serotonin in pulmonary arteries has been implicated in the pathobiology of pulmonary arterial hypertension (PAH). The incidence of PAH associated with diet pills such as aminorex, fenfluramine, and chlorphentermine initially led to the "serotonin hypothesis of pulmonary hypertension." Over the last couple of decades there has been an accumulat...

متن کامل

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans

BACKGROUND Serotonin promotes pulmonary arterial vasoconstriction and pulmonary arterial smooth muscle cell proliferation, thereby having the potential to increase pulmonary arterial blood pressure. Although serotonin reuptake inhibitors (SRIs) might inhibit further deterioration in patients with manifest pulmonary arterial hypertension, they may induce pulmonary hypertension in healthy newborn...

متن کامل

Genetic association of the serotonin transporter in pulmonary arterial hypertension.

RATIONALE The bone morphogenetic receptor type II gene is the major genetic determinant for the inherited form of pulmonary arterial hypertension. However, deleterious mutations of this gene are not observed in the majority of subjects who develop the condition spontaneously and familial disease displays age- and sex-dependent penetrance, indicating the requirement for additional environmental ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Circulation research

دوره 94 9  شماره 

صفحات  -

تاریخ انتشار 2004